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A novel ferrocene-derived substrate for the ratiometric 5 
electrochemical detection of alkaline phosphatase (ALP) was 
designed and synthesised. The substrate was demonstrated to 
be an excellent electrochemical substrate for ALP-labelled 
enzyme-linked immunosorbent assays (ELISA). 
Alkaline phosphatase (ALP, EC 3.1.3.1) is one of the most 10 
commonly assayed enzymes as abnormal levels in serum can be 
used to preliminarily diagnose several diseases such as bone 
disease,1 liver dysfunction,2 breast and prostatic cancer,3 and 
diabetes.4 Moreover, ALP is extensively used as an enzyme-label 
within enzyme-linked immunosorbent assays (ELISA) due to 15 
being easily conjugated to antibodies, inexpensive and has high 
catalytic activity.5 Typically, ALP is detected photometrically 
using p-nitrophenyl phosphate (pNPP),6 or fluorimetrically using 
4-methylumbelliferyl phosphate (4-MUP).7 Chemiluminescence 
has also been employed to determine ALP activity.8 However, to 20 
circumvent problems associated with these spectroscopic 
techniques, such as the use of expensive optical equipment and 
the need for transparent samples, there has been considerable 
demand for the development of electrochemical enzyme 
substrates. Importantly, these substrates have potential 25 
application within the development of electrochemical biosensors 
for point-of-care medical diagnostics.9 In recent years, there has 
been tremendous progress made in this area of research and in 
particular, in the development of electrochemical enzyme-
labelled immunoassays.10 The main focus in improving the 30 
sensitivity of electrochemical immunoassays has been aimed 
towards immunosensor fabrication or electrode modification.11 
However, an area in which there is still a considerable 
opportunity for progress, is in the development of 
electrochemical substrates for enzymes. 35 
 Phenyl phosphate can be used as an electrochemical substrate 
for ALP but the electro-active product, phenol, requires 
separation, either by liquid chromatography (LC) or flow 
injection analysis (FIA), prior to electrochemical analysis.12 
Electron-rich phenyl phosphates can give improved signals but 40 
the electron-rich phenol products are prone to electro-
polymerisation, which contributes to undesirable electrode 
fouling.13 A commonly used electrochemical substrate for ALP is 
L-ascorbic acid 2-phosphate (AA2P) as it is inexpensive and 
electro-inactive.14 In the presence of ALP, AA2P is converted to 45 
ascorbic acid which is electro-active, giving a ‘turn-on’ 
electrochemical detection system. Sensitivity is compromised 
however, as the product requires acidic media to deliver optimal 
current, which conflicts with the ideal pH of the enzyme. 
 Ferrocene is often used as the redox-active moiety of 50 
electrochemical probes due to its easy derivatisation and 
favourable electrochemical properties.15 Moreover, ferrocene 
exhibits excellent stability in aqueous media and its derivatives 
have therefore been widely used in biological applications.16 
Despite this, few ferrocene phosphate derivatives have been 55 
reported in the literature designed for use as electrochemical 
substrates for ALP. Bannister et al. describe the amperometric 
determination of ALP activity using [N-ferrecenoyl]-4-
aminophenyl phosphate.17 Unfavourably, this system relies on the 
product generating a greater signal than the substrate as both 60 
substrate and product have similar oxidation potentials. Degrand 
et al. describe the use of modified-electrodes in order to 
distinguish between a similar ferrocene-phenyl phosphate 
substrate and the corresponding ferrocene-phenol product.18 
However, the fabrication of modified electrodes is time-65 
consuming and the electrodes are not reusable. To the best of our 
knowledge, a ferrocene-derived electrochemical substrate for 
ALP in which substrate and product have significantly different 
oxidation potentials is yet to be described. 
 70 
Scheme 1 Structure of substrate 1 and proposed mechanism of ALP-
catalysed breakdown with subsequent release of compound 3. 
 Continuing our interest in ferrocene-based electrochemical 
sensing,19 we designed ferrocenylphenyl phosphate 1 as an 
electrochemical substrate for ALP  inspired by trigger-linker-75 
effector sensing methodologies.20 We proposed that in the 
presence of ALP, dephosporylation would occur giving rise to an 
unstable phenolate intermediate 2, which would undergo 1,6-
elimation and release ferrocenylamine 3, along with an equivalent 
of quinone methide and CO2 (Scheme 1). In principle, 80 
ferrocenylamine would be oxidised at a lower potential than that 
of the substrate due the increased electron density around the iron 
centre.21 Therefore, 3 would be electrochemically distinguishable 
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from 1 and as a result, we would be able to monitor ALP activity 
ratiometrically using electrochemical analysis. Electrochemical 
ratiometric analysis has the benefit of being able to obtain 
reaction conversions, thus minimising sampling errors or errors 
that occur through instrument/electrode variations. 5 
 
Scheme 2 Synthesis of substrate 1. 
 The synthesis of substrate 1 (Scheme 2) began with 
ferrocenecarboxylic acid being converted to ferrocenoyl azide 4, 
which was synthesised according to a literature procedure.22 10 
Curtius rearrangement of 4 in the presence of benzyl alcohol 5 
(see SI for synthesis) generated the desired protected phosphate 6. 
Polymer-bound palladium-catalysed deallylation followed by 
sodium salt formation gave phosphate 1 in 40% overall yield. 
Once synthesised, substrate 1 is a bench-stable solid with no 15 
decomposition observed for several weeks. Also, high 
concentrations of substrate 1 in buffer solution are stable to 
hydrolysis for a week at room temperature.  With substrate 1 in 
hand, its electrochemical behaviour was analysed via differential 
pulse voltammetry (DPV) and compared to that of 20 
ferrocenylamine 3. 
 
Fig. 1 Differential pulse voltammogram obtained for substrate 1 (100 
µM) and ferrocenylamine 3 (100 µM) in 0.05 M pH 9 Tris buffer. 
 Expectedly, 3 has a much lower oxidation potential than that of 25 
1, a difference of approximately 230 mV, which is considerable 
enough that both peaks do not overlap (Figure 1). As a result, the 
peaks can be individually integrated and the conversion of 
substrate to product can be calculated using equation 1. 
                  
  
        
        (1) 30 
 Substrate 1 (100 µM) was then exposed to varying 
concentrations of ALP in 50 mM pH 9 tris buffer at room 
temperature (~25 °C) and sampled every 3 minutes for 30 
minutes (Figure 2). DPV was performed on each sample and the 
reaction conversion calculated by equation 1. At ALP 35 
concentrations higher than 500 UL
-1
, quantitative conversions 
were observed within 10 minutes. Full conversions were also 
seen within 30 minutes at ALP concentrations as low as 175 UL
-
1
. Pleasingly, a minimal background reaction is observed and as 
such, this allows for ALP concentrations as low as 5 UL
-1 
to be 40 
detected in 30 minutes under these conditions. 
 
Fig. 2 Conversion of substrate (100 µM) to product after addition of 
different concentrations of ALP at room temperature. 
 Next, the optimal concentration of substrate 1 was investigated 45 
(Figure 3). An ALP concentration of 100 UL
-1
 was chosen as this 
would allow for both positive and negative effects of changing 
substrate concentration to be clearly identified. Increasing the 
concentration of substrate 1 from 100 µM did not elicit 
discernible increases in the rate of reaction. However, halving the 50 
concentration of substrate 1 allowed for quantitative conversion 
to be observed in 15 minutes. Further decreases of substrate 
concentration provide slightly increased reaction rates but due to 
both a lower current return and an increase in background 
hydrolysis, we decided to continue our investigation using a 55 
substrate concentration of 50 µM. 
 
Fig. 3 Conversion of substrate to product after addition of ALP (100 UL
-
1
) using different concentrations of substrate at room temperature. 
 The optimum working temperature of ALP is 37 °C,6a and as 60 
such, the effect of temperature on the reaction of ALP with 
substrate 1 was studied next. Accordingly, the reaction was 
screened against varying concentrations of ALP at 37 °C with the 
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optimised substrate concentration (Figure 4). As desired, the 
reaction rates increased from previous results as quantitative 
conversions were now observed for ALP concentrations of 50 
UL
-1
 or higher in 21 minutes. The limit of detection (LOD) for 
ALP was determined (see SI) to be 0.4 UL
-1
 after 27 minutes at 5 
37 °C under these reaction conditions, which compares 
favourably to other electrochemical substrates.23 
 
Fig. 4 Conversion of substrate (50 µM) to product after addition of 
different concentrations of ALP at 37 °C.  10 
 
Fig. 5 Amperometric response of ferrocenylamine released from substrate 
1 (50 µM) after the addition of ALP in different concentrations. Error bars 
indicate standard deviations (n = 3). LOD calculated as 3 × standard 
deviations higher than the mean. 15 
 
 With our reaction conditions now optimised, we next looked 
towards the application of substrate 1 within immunoassays. Prior 
to this, tests with substrate 1 with conjugated derivatives of ALP 
were needed. Streptavidin-conjugated ALP is often used in 20 
immunoassays to couple the enzyme to biotinylated antibodies, 
taking advantage of the high binding affinity between streptavidin 
and biotin.24 However, enzyme conjugation can often lead to 
denaturisation and consequently a loss of enzyme activity.5 As 
such, we applied our substrate to commercially-available 25 
streptavidin-ALP (Figure 5). Pleasingly, enzyme‒protein 
conjugation does not lead to deactivation of the enzyme towards 
our substrate. Concentrations of conjugated ALP higher than 25 
ngL
-1
 delivers full conversion of the substrate within 30 minutes. 
A concentration of 0.5 ngL
-1
 can also be distinguished from the 30 
background rate within this time period. 
 
Fig. 6 Conversion of substrate (50 µM) to product after addition of 
different concentrations of ALP at 37 °C. 
    Encouraged by these results, we then applied substrate 1 to a 35 
commercial ELISA kit for the detection of the inflammation 
biomarker, C-reactive protein (CRP).25 The sandwich 
immunoassay was constructed according to the manufacturer’s 
procedure (see SI) and then exposed to substrate 1 under the 
optimised conditions (Scheme 3). Comparatively, we also used L-40 
ascorbic acid 2-phosphate (AA2P), a literature electrochemical 
substrate for ALP,14 as the immunoassay substrate to determine 
the benefits of using a ratiometric ferrocene-based 
electrochemical substrate over a ‘switch-on’ organic-based  
substrate. The substrate was incubated at 37 °C for 30 minutes 45 
prior to measuring the current obtained at the oxidation potential 
of the product. 
 
Scheme 3 An illustration of the ELISA format for CRP immunoassay 
used. Electrochemical detection obtained using DPV with either 1 or 50 
AA2P as the substrate. 
 Gratifyingly, good responses were achieved using substrate 1 
as the enzyme substrate for the CRP immunoassay with over 100 
nA detected at CRP concentrations of 30 and 100 µgL
-1
. This is 
over a 7-fold increase in current compared with AA2P at these 55 
concentrations. Positive current was still obtained at the lowest 
concentration (1 µgL
-1
) of CRP tested. In comparison, no 
discernible signal was seen at this concentration when AA2P was 
used. 
 In conclusion, we have described the first example of 60 
ratiometric electrochemical detection for alkaline phosphatase 
activity. A novel ferrocene-based substrate, charged with a 
phosphate trigger, was synthesised and found to be 
electrochemically distinguishable from the product via 
differential pulse voltammetry. The compound synthesised was 65 
shown to be an efficient substrate for alkaline phosphatase and 
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demonstrated the detection of low concentrations of both protein-
conjugated and unconjugated enzyme. The substrate was also 
successfully applied to an alkaline phosphatase-labelled ELISA 
for the ratiometric electrochemical detection of CRP, which 
delivered up to a 7-fold increase in current compared with that of 5 
commonly used electrochemical substrate. 
 
Fig. 7 Current measured from CRP ELISA using substrate 1 and AA2P as 
electrochemical. Error bars indicate standard deviations (n = 6). 
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